Stay updated on Reslizumab in EGPA: Clinical Trial
Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest updates to the Reslizumab in EGPA: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference4%
- Check41 days agoChange DetectedSeveral key health-related links have been removed, including those related to granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis, which may impact access to important genetic and disease information.SummaryDifference0.7%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added related to granulomatosis with polyangiitis and other related conditions, while the previous version 2.12.1 has been removed.SummaryDifference5%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Reslizumab in EGPA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.